Bio Protocol

@BioProtocol

Biotech's new financial layer.

app.bio.xyz

Joined May 2022

Replies Reposts Media Articles

Pinned
Bio Protocol
@BioProtocol
Aug 7
July in the Biosphere 🌐 • The White House published a report, "Science: A New Golden Age," calling to fund scientists directly and make research open and auditable. Much of it reads like the case Bio has made for years. • PeptAI's next experiments are heading to a real lab.
Bio Protocol
@BioProtocol
Aug 7
Article
Bio Monthly (July 2026): The White House Backs Open Science, PeptAI Goes to the Lab, Research Agents
Highlights from July in the Biosphere 🌐 This month the White House published a report, "Science: A New Golden Age." Its recommendations align closely with what Bio has been building. It calls for...
Bio Protocol
@BioProtocol
Aug 26
Congratulations to @adaptyvbio on the $40M. The line worth reading twice is that AI can only move as fast as the experiments behind it. Building throughput on the physical side is slower and less glamorous than model work, and it's what the whole field is actually waiting on.
Adaptyv Bio
@adaptyvbio
Aug 25
We raised a $40M Series A to build the automated lab for agentic biology. Last week, we shared the work we did with @Anthropic: Claude designed proteins, sent them to our automated wet lab, and got real experimental data back. We believe this is where biology is going: AI
00:00
Bio Protocol
@BioProtocol
Aug 23
Science pays for the same failure many times over, and nobody involved is doing anything wrong. A lab spends two years on an approach and it doesn't work. That result closes a door, and there are only so many doors, which makes it worth knowing. It goes nowhere. No journal
00:00
Bio Protocol
@BioProtocol
Aug 22
A condition affecting eight thousand people costs about the same to research as one affecting eight million. Same trial design, decade, and regulators. What changes is who you sell the answer to. So for eight thousand people, the answer mostly doesn't get looked for. They
Bio Protocol
@BioProtocol
Aug 20
A cancer therapy cleared Phase 3 yesterday that was made for exactly one person. Sequenced from her tumour, built for her immune system, never manufactured again. For a century medicine has meant a compound discovered once and given to everyone it fits. That model built most of
Moderna
@moderna_tx
Aug 19
Along with our partners at @Merck, we announced positive results from the Phase 3 INTerpath-001 study of intismeran autogene, our investigational individualized neoantigen therapy, in combination with pembrolizumab as adjuvant treatment in patients with completely resected Stage